Latest Cambridge News | Page 7

PolyU research discovers nanoscale ferroelectric new materials exhibiting potential for making computer memory with low cost and low energy consumption
CSIRO researchers help deliver food security with major international grant
NZ police investigating Hamilton aggravated robbery
Four drink drivers caught in Kingston
Council delivers final stage of Playspace Shade Program
Serotonin 2C receptor associated with obesity and maladaptive behavior
NZ police make arrests after burglaries overnight
Improving understanding, collaboration throughout energy supply chain
Cambridge University-Tokyo Tech Joint Online Workshop Growing opportunities for research exchange and collaboration
Cumberland City Council rolls out additional Community Reading Boxes to encourage families to discover new books
Queensland and Sanofi to establish global vaccine hub
Appointment of Judge of High Court 2 December
National science agency supercharges environmental focus with new business unit
Orange Regional Gallery’s growing collection on show in latest exhibition
AstraZeneca announces sale of its West Chester, Ohio manufacturing site
AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy
Young people’s wellbeing falls sharply after starting secondary school
Former teacher appearing in court on historic charges
Heart rhythm clues in regular pulse check could stop stroke
Queensland’s high-tech plan to make 2032 Brisbane Olympic Games smarter and greener
NZ police appeal for sightings of red vehicle before crash south of Cambridge
‘Gain of function’ research can create experimental viruses
Imfinzi plus chemotherapy recommended for approval in EU by CHMP as first immunotherapy regimen for advanced biliary tract cancer
Study sheds new light on benefits to children of water fluoridation
AstraZeneca expands global footprint in rare disease with availability of first Alexion rare disease therapy for patients
Imfinzi and Imjudo with chemotherapy approved in US for patients with metastatic non-small cell lung cancer
Farxiga improved symptom burden and health-related quality of life
AstraZeneca presents data at ASN Kidney Week 2022 reinforcing urgent need for early screening of chronic kidney disease and benefits
AstraZeneca funds R&D Postdoctoral Challenge finalists
Vaxzevria receives full Marketing Authorisation in EU for prevention of Covid
West Leederville Robbery Investigation
Cambridge Police community engagement day
Scientists warn of Earth’s unequivocal climate emergency
Awapuni on track for regional racing boost
Camizestrant significantly improved progression-free survival in advanced ER-positive breast cancer
Capivasertib Phase III trial met primary endpoints
Update on MESSINA Phase III trial for Fasenra in eosinophilic esophagitis
Waikato Police investigating commercial incidents overnight
Imjudo in combination with Imfinzi approved in US for patients with unresectable liver cancer
Identifying new pathways to treat cardiovascular disease
IDWeek data reinforces AstraZeneca’s commitment to advance science in vaccines and immune therapies
$4 million boost to help local governments reduce groundwater use
New recreation spaces for Trinity Drive Reserve
UK joins mission to search for origins of Universe
Artist’s sculptures inspired by wondrous world
First Australian Boat Race in three years comes to nail-biting end
North Queensland is pumped for major hydro milestone
Baffling ‘spiderweb’ star not ‘alien megastructure’